背景:鼻部手术,解决形式和功能的解剖学变化,需要仔细的麻醉管理,包括右美托咪定和瑞芬太尼。这项荟萃分析评估了它们在鼻手术中的安全性和有效性变化,强调患者的舒适度和最佳结果。
方法:四个电子数据库(PubMed,Scopus,WebofScience,和CINAHLComplete)搜索英文记录。包括测量右美托咪定与瑞芬太尼对鼻腔手术患者的影响的研究。Cochrane协作工具用于评估纳入研究的质量。优选随机效应模型,并通过Stata软件版本17进行统计分析。
结果:在最初的63篇文章中,本分析选择了5项研究.所有这些选择的研究都是随机对照试验(RCTs)。荟萃分析共涉及302名参与者,瑞芬太尼组152例,右美托咪定组150例。比较右美托咪定和瑞芬太尼对术中心率(HR)和平均动脉压(MAP)的影响。两组均表现出相似的MAP和HR,瑞芬太尼组在手术第15分钟时的HR略低(标准化平均差:-0.24[-0.83,0.34])。此外,在评估这些药物对术后结果的影响时,包括疼痛程度,使用止痛药,患者-外科医生满意度,躁动分数,和恢复时间,两种药物在这些方面均无显著差异.
结论:总之,本研究比较了右美托咪定和瑞芬太尼在鼻部手术麻醉中的应用。在心率方面没有发现显著差异,血压,满意,疼痛,激动,或恢复时间。这项研究有局限性,未来的研究应该建立标准化的方案,并考虑各种手术因素。
BACKGROUND: Nasal surgeries, addressing anatomical variations for form and function, require careful anesthesia administration, including dexmedetomidine and remifentanil. This meta-analysis evaluates their safety and efficacy variations in nasal surgeries, emphasizing patient comfort and optimal outcomes.
METHODS: Four electronic databases (PubMed, Scopus, Web of Science, and CINAHL Complete) were searched for records in English. Studies that measure the effect of dexmedetomidine versus remifentanil on patients underwent nasal surgery were included. The Cochrane Collaboration\'s tool was used to assess the quality of the included studies. A random-effect model was preferred and statistical analysis was performed by Stata software version 17.
RESULTS: Out of an initial pool of 63 articles, five studies were selected for this analysis. All of these chosen studies were Randomized Controlled Trials (RCTs). The meta-analysis involved a total of 302 participants, with 152 in the remifentanil group and 150 in the dexmedetomidine group. The analysis aimed to compare the effects of Dexmedetomidine and Remifentanil on heart rate (HR) and mean arterial pressure (MAP) during surgery. Both groups exhibited similar MAP and HR, with the exception of a slightly lower HR in the remifentanil group at the 15th minute of surgery (Standardized Mean Difference: -0.24 [-0.83, 0.34]). Furthermore, when evaluating the impact of these medications on post-surgery outcomes, including pain levels, the use of pain relief medications, patient-surgeon satisfaction, agitation scores, and recovery time, no significant differences were observed between the two medications in any of these aspects.
CONCLUSIONS: In summary, the study compared Dexmedetomidine and Remifentanil in nasal surgeries anesthesia. No significant differences were found in heart rate, blood pressure, satisfaction, pain, agitation, or recovery time. The study had limitations, and future research should establish standardized protocols and consider various surgical factors.